TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/8/24 17:28 | 3/7/24 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Gannon Steven | A1 | D | S | -602 | 46.28 | 0 | -13 | -87 | 2 | D | |||||||||||||||
8/11/22 16:19 | 8/11/22 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Gannon Steven | MA | D | P | 90 | 2.03 | 0 | 44 | 370 | 56 | D | |||||||||||||||
8/23/21 18:28 | 8/23/21 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Gannon Steven | MA | D | P | 23 | 7.99 | 0 | 3 | 31 | 12 | D | |||||||||||||||
8/20/21 16:10 | 8/18/21 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Gannon Steven | MA | D | P.m | 26 | 8.05 | 0 | 3 | 53 | 9 | D | |||||||||||||||
8/17/21 16:05 | 8/16/21 | FUSN | Fusion Pharmaceuticals Inc. | Z4 | Health | BioPrd | Biological Products, (No Diag | Gannon Steven | MA | D | P | 49 | 8.10 | 0 | 6 | New | 6 | D | |||||||||||||||
8/14/17 18:05 | 8/11/17 | XENE | Xenon Pharmaceuticals Inc. | A1 | Health | Drug | Pharmaceutical Preparations | Gannon Steven | A1 | D | P | 42 | 2.82 | 0 | 15 | New | 15 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |